{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:33:46Z","timestamp":1791297226962,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.clinthera.2011.09.006","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T19:58:38Z","timestamp":1319745518000},"page":"1659-1667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hip and Subtrochanteric or Diaphyseal Femoral Fractures in Alendronate Users: A 10-Year, Nationwide Retrospective Cohort Study in Taiwanese Women"],"prefix":"10.1016","volume":"33","author":[{"given":"Fei-Yuan","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng-Foung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsiang","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Kung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.09.006_bib1","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.amjmed.2008.12.003","article-title":"Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis","volume":"122","author":"Bilezikian","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2011.09.006_bib2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.09.006_bib3","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.09.006_bib4","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/archinte.168.8.826","article-title":"Use of alendronate and risk of incident atrial fibrillation in women","volume":"168","author":"Heckbert","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.006_bib5","first-page":"30","article-title":"Bisphosphonate-related osteonecrosis of the jaw","volume":"66","author":"Feller","year":"2011","journal-title":"SADJ"},{"key":"10.1016\/j.clinthera.2011.09.006_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/gme.0b013e3181b34749","article-title":"Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene","volume":"17","author":"Huang","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.clinthera.2011.09.006_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.mlg.0000240885.64568.9e","article-title":"Osteonecrosis of the jaw associated with bisphosphonate use: presentation of seven cases and literature review","volume":"117","author":"Mortensen","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.clinthera.2011.09.006_bib8","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s11999-009-1192-0","article-title":"Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy","volume":"468","author":"Cermak","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.clinthera.2011.09.006_bib9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2214\/AJR.09.3588","article-title":"Subtrochanteric femoral fractures in patients receiving long-term alendronate therapy: imaging features","volume":"194","author":"Chan","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinthera.2011.09.006_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","author":"Kwek","year":"2008","journal-title":"Injury"},{"key":"10.1016\/j.clinthera.2011.09.006_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11914-010-0007-2","article-title":"Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates","volume":"8","author":"Nieves","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.clinthera.2011.09.006_bib12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1359\/jbmr.081247","article-title":"Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study","volume":"24","author":"Abrahamsen","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2011.09.006_bib13","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1210\/jc.2010-1571","article-title":"Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis","volume":"95","author":"Abrahamsen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2011.09.006_bib14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","article-title":"Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur","volume":"362","author":"Black","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.09.006_bib15","first-page":"99","article-title":"Using Taiwan national health insurance research databases for pharmacoepidemiology research","volume":"15","author":"Hsiao","year":"2007","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.clinthera.2011.09.006_bib17","series-title":"Fundamentals of Biostatistics","author":"Rosner","year":"2000"},{"key":"10.1016\/j.clinthera.2011.09.006_bib18","series-title":"Applied Survival Analysis: Regression Modeling of Time to Event Data","author":"Hosmer","year":"2008"},{"key":"10.1016\/j.clinthera.2011.09.006_bib19","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2011.09.006_bib20","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"1","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2011.09.006_bib21","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial","volume":"85","author":"Black","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2011.09.006_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2006.11.001","article-title":"Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass","volume":"40","author":"Recker","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.clinthera.2011.09.006_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2796.2004.01317.x","article-title":"Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International","volume":"255","author":"Sambrook","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2011.09.006_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00223-009-9263-5","article-title":"Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series","volume":"85","author":"Armamento-Villareal","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clinthera.2011.09.006_bib25","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181100614X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181100614X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:48Z","timestamp":1758962928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929181100614X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S014929181100614X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.09.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hip and Subtrochanteric or Diaphyseal Femoral Fractures in Alendronate Users: A 10-Year, Nationwide Retrospective Cohort Study in Taiwanese Women","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier HS Journals, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}